Last reviewed · How we verify
vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects patent landscape — cliff calendar, originator estates, attackable patents
- vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects treatment landscape brief
- vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects treatment updates RSS
Related
- Treatment landscape: vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects patent cliff · vancomycin resistant enterococcus extended spectrum beta lactamase producing enterobacteriaceae or carbapenem resistant enterobacteriaceae colonized subjects CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing